Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Athersys Inc (NQ: ATHX )

2.130 USD -0.020 (-0.93%)
Streaming Delayed Price Updated: 7:01 AM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Athersys Inc

< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Biotech Market Value Set to Grow Due to Technological Advancements
FinancialBuzz.com News Commentary 
From PR Newswire
Benzinga's Daily Biotech Pulse: FDA Panel Nod For Akcea, Synergy's Revenue Miss, FDA Warns E-Liquid Makers Again
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags HTGM ADMP APTO
From Benzinga
Athersys Reports First Quarter 2018 Results
Management to host conference call at 4:30pm EDT today 
From GlobeNewswire News Releases
Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags AMAG EGRX News
From Benzinga
NASDAQ:ATHX Shareholder Notice: Investigation of Athersys, Inc. Announced
San Diego, CA -- (SBWIRE) -- 05/09/2018 -- Athersys, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
From SBWire - Latest Press Releases
The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More
After eking out a modest gain in the week ended April 27, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) pulled back ... 
Tags BCRX INFI ARNA
From Benzinga
Athersys and Healios Extend by One Month the Period to Complete Collaboration Expansion Agreements
Athersys, Inc. (NASDAQ:ATHX) and HEALIOS K.K. (“Healios”) (TSE Mothers Code:4593) have agreed to extend the period from April 30, 2018 to May 31, 2018 to complete their planned collaboration expansion... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Delaware Law by the Board of Athersys, Inc. -- ATHX
Levi & Korsinsky announces it has commenced an investigation of Athersys, Inc. 
From Business Wire News Releases
Recent Analysis Shows First Cash, ADTRAN, OMNOVA Solutions, Athersys, Oppenheimer, and Conn's Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of First Cash, Inc.... 
From GlobeNewswire News Releases
UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients
Pioneering Phase 2 study of cell therapy in Trauma to be conducted at major Level 1 Trauma Center in the U.S. with funding from MTEC Grant Award 
From GlobeNewswire News Releases
Athersys to Host First Quarter Financial Results Call
Athersys, Inc. (Nasdaq:ATHX) will release its first quarter 2018 financial results at approximately 4:00 PM Eastern Time on Thursday, May 10, 2018, and will host a conference call shortly thereafter at... 
From GlobeNewswire News Releases
BRIEF-Healios K.K. Reports 8.7 Pct Stake In Athersys
* HEALIOS K.K. REPORTS 8.7 PERCENT STAKE IN ATHERSYS INC AS OF MARCH 13, 2018 - SEC FILING?? Source text: (https://bit.ly/2G0glmi) 
Tags companyNews
From Reuters: Company News
Athersys to Present at Needham Healthcare Conference on March 28
Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the 17th Annual Needham Healthcare Conference at The Westin Grand Central... 
From GlobeNewswire News Releases
Healthcare Companies Capitalizing on a Resurgent Biotech Industry
From PR Newswire
45 Biggest Movers From Yesterday
Gainers Proteostasis Therapeutics Inc (NASDAQ: PTI) shares climbed 54.11 percent to close at $6.38 on Tuesday after the ... 
Tags CUTR AVGO MYGN
From Benzinga
Athersys Reports Financial Results for Fourth Quarter, Full Year 2017
Athersys, Inc. (NASDAQ:ATHX) announced today its fourth quarter 2017 and annual 2017 financial results and highlights. 
From GlobeNewswire News Releases
35 Stocks Moving In Tuesday's Mid-Day Session
Gainers Proteostasis Therapeutics Inc (NASDAQ: PTI) shares jumped 65.6 percent to $6.86 after the biopharmaceutical company ... 
Tags MNOV DSW INNT
From Benzinga
Benzinga Pro's 5 Stock To Watch Today
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a ... 
Tags PLX Pre/Market Outlook AVGO
From Benzinga
Athersys and HEALIOS Announce Binding Letter of Intent to Expand MultiStem® Collaboration
Athersys, Inc. (NASDAQ:ATHX) and HEALIOS K.K. (“Healios”) announced today their intent to significantly expand their existing development and commercialization collaboration. As part of this expansion,... 
From GlobeNewswire News Releases
BRIEF-Athersys and Healios announce binding letter of intent to expand multistem collaboration
* ATHERSYS AND HEALIOS ANNOUNCE BINDING LETTER OF INTENT TO EXPAND MULTISTEM® COLLABORATION 
Tags companyNews
From Reuters: Company News
The Week Ahead In Biotech: Earnings, PDUFA Dates And More
The FDA issued mostly positivedecisions on the approval front last week. Theratechnologies Inc. (OTC: THERF) shares gained ... 
Tags EPZM INFI ARNA
From Benzinga
Commit To Purchase Athersys At $1, Earn 24.1% Annualized Using Options
Investors eyeing a purchase of Athersys Inc (ATHX) stock, but cautious about paying the going market price of $1.51/share, might benefit from considering selling puts among the alternative strategies... 
Tags Stocks
From Market News Video
Report: Exploring Fundamental Drivers Behind BWX Technologies, WMIH, Conn's, Athersys, Proofpoint, and Kindred Healthcare — New Horizons, Emerging Trends, and Upcoming Developments
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of BWX Technologies, Inc.... 
From GlobeNewswire News Releases
Athersys to Host Year-End 2017 Financial Results Call
Athersys, Inc. (Nasdaq:ATHX) will release its year-end 2017 financial results at approximately 4:00 PM Eastern Time on Tuesday, March 13, 2018, and will host a conference call shortly thereafter at... 
From GlobeNewswire News Releases
BRIEF-Athersys Inc Files Prospectus Relates Potential Sale Of Up To 24.7 mln Shares Of Co's Common Stock By Aspire Capital
* ATHERSYS INC FILES PROSPECTUS RELATES POTENTIAL SALE OF UP TO 24.7 MILLION SHARES OF CO'S COMMON STOCK BY ASPIRE CAPITAL - SEC FILING?? Source text - (http://bit.ly/2nyf89E) Further company... 
Tags companyNews
From Reuters: Company News
BRIEF-Athersys Enters Into New $100 Mln Equity Facility With Aspire Capital
* ATHERSYS ENTERS INTO NEW $100 MILLION EQUITY FACILITY WITH ASPIRE CAPITAL 
Tags companyNews
From Reuters: Company News
Athersys Enters Into New $100 Million Equity Facility with Aspire Capital
Athersys, Inc. (NASDAQ:ATHX) and Aspire Capital Fund, LLC (“Aspire Capital”) announced today that a new equity facility has been established, as a follow-on to a current facility. Under the new... 
From GlobeNewswire News Releases
BRIEF-Athersys Says On Feb 1, Co Entered Into Common Stock Purchase Agreement With Aspire Capital Fund
* ATHERSYS INC SAYS ON FEB 1, CO ENTERED INTO COMMON STOCK PURCHASE AGREEMENT WITH ASPIRE CAPITAL FUND - SEC FILING 
Tags companyNews
From Reuters: Company News
This Morning's Technical Outlook on Biotech Stocks -- Aptose Biosciences, Athersys, AVEO Pharma, and Aviragen Therapeutics
From PR Newswire
Athersys CEO to Speak at the 2018 Brain Health Summit
Event held in conjunction with Super Bowl LII will focus on key issues in neurological medicine and women’s brain health 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.